TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - EVOTEC Share Price

Certificat

DE000SU4GCS0

Real-time Boerse Frankfurt Warrants 17:49:39 28/05/2024 BST
1.12 EUR +0.90% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - EVOTEC
Current month+4.72%
1 month+0.91%
Date Price Change
28/05/24 1.12 +0.90%
27/05/24 1.11 -1.77%
24/05/24 1.13 +1.80%
23/05/24 1.11 +2.78%
22/05/24 1.08 +0.93%

Real-time Boerse Frankfurt Warrants

Last update May 28, 2024 at 05:49 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying EVOTEC SE
IssuerLogo Issuer Société Générale Société Générale
WKN SU4GCS
ISINDE000SU4GCS0
Date issued 04/01/2024
Strike 20.22
Maturity Unlimited
Parity 10 : 1
Emission price 0.31
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.16
Lowest since issue 0.19

Company Profile

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Sector
-
More about the company

Ratings for Evotec SE

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Evotec SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
9.18 EUR
Average target price
20.79 EUR
Spread / Average Target
+126.47%
Consensus